Cargando…
Clinical Prediction Models for Valvular Heart Disease
BACKGROUND: While many clinical prediction models (CPMs) exist to guide valvular heart disease treatment decisions, the relative performance of these CPMs is largely unknown. We systematically describe the CPMs available for patients with valvular heart disease with specific attention to performance...
Autores principales: | Wessler, Benjamin S., Lundquist, Christine M., Koethe, Benjamin, Park, Jinny G., Brown, Kristen, Williamson, Tatum, Ajlan, Muhammad, Natto, Zuhair, Lutz, Jennifer S., Paulus, Jessica K., Kent, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818049/ https://www.ncbi.nlm.nih.gov/pubmed/31583938 http://dx.doi.org/10.1161/JAHA.119.011972 |
Ejemplares similares
-
Tufts PACE Clinical Predictive Model Registry: update 1990 through 2015
por: Wessler, Benjamin S., et al.
Publicado: (2017) -
Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis
por: Pan, Kuo‐Li, et al.
Publicado: (2017) -
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
por: Li, Wei-Jia, et al.
Publicado: (2021) -
Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
por: Sitticharoenchai, Patita, et al.
Publicado: (2021) -
Partial vena cava occlusion (VCO) to counteract refractory heart failure: A new era in interventional heart failure strategy
por: Sattar, Yasar, et al.
Publicado: (2021)